Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000000170 | SCV000800458 | pathogenic | Ornithine aminotransferase deficiency | 2018-06-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000000170 | SCV001585188 | pathogenic | Ornithine aminotransferase deficiency | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.His53Glnfs*8) in the OAT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OAT are known to be pathogenic (PMID: 1737786, 23076989). This variant is present in population databases (rs386833599, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with gyrate atrophy (PMID: 1737786, 28388263). ClinVar contains an entry for this variant (Variation ID: 147). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV000000170 | SCV002780563 | pathogenic | Ornithine aminotransferase deficiency | 2024-06-21 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000000170 | SCV004208963 | pathogenic | Ornithine aminotransferase deficiency | 2024-03-24 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000000170 | SCV000020313 | pathogenic | Ornithine aminotransferase deficiency | 1992-02-15 | no assertion criteria provided | literature only | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000000170 | SCV000081963 | probable-pathogenic | Ornithine aminotransferase deficiency | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. | |
Sharon lab, |
RCV000000170 | SCV001161171 | pathogenic | Ornithine aminotransferase deficiency | 2019-06-23 | no assertion criteria provided | research | |
Natera, |
RCV000000170 | SCV002086408 | pathogenic | Ornithine aminotransferase deficiency | 2020-04-13 | no assertion criteria provided | clinical testing |